FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagede.medizininformatikinitiative.kerndatensatz.onkologie
Resource TypeProcedure
IdProcedure-mii-exa-onko-palbociclib-therapie.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

No narrative content found in resource


Source1

{
  "resourceType": "Procedure",
  "id": "mii-exa-onko-palbociclib-therapie",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-systemische-therapie|2026.0.2"
    ]
  },
  "extension": [
    {
      "url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-ex-onko-systemische-therapie-intention",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-intention",
            "code": "K"
          }
        ]
      }
    }
  ],
  "code": {
    "coding": [
      {
        "system": "http://fhir.de/CodeSystem/bfarm/ops",
        "code": "8-54",
        "display": "Zytostatische Chemotherapie, Immuntherapie und antiretrovirale Therapie",
        "version": "2024"
      },
      {
        "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-systemische-therapie-art",
        "code": "ZS"
      }
    ],
    "text": "Palbociclib"
  },
  "status": "preparation",
  "category": {
    "coding": [
      {
        "code": "18629005",
        "system": "http://snomed.info/sct"
      }
    ]
  },
  "subject": {
    "reference": "Patient/example"
  },
  "basedOn": [
    {
      "reference": "CarePlan/mii-exa-onko-tumorkonferenz-molekular"
    }
  ],
  "performedPeriod": {
    "start": "2024-02-15"
  },
  "partOf": [
    {
      "reference": "Procedure/mii-exa-onko-trastuzumab-therapie"
    }
  ],
  "note": [
    {
      "text": "Implements CarePlan activity[0]: Anti-HER2 targeted therapy"
    }
  ]
}